Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Regenxbio (RGNX) Interest Expenses (2021 - 2025)

Regenxbio (RGNX) has 7 years of Interest Expenses data on record, last reported at $12.3 million in Q4 2025.

  • For Q4 2025, Interest Expenses rose 30.36% year-over-year to $12.3 million; the TTM value through Dec 2025 reached $45.0 million, up 255.54%, while the annual FY2025 figure was $45.0 million, 255.54% up from the prior year.
  • Interest Expenses reached $12.3 million in Q4 2025 per RGNX's latest filing, down from $13.2 million in the prior quarter.
  • Across five years, Interest Expenses topped out at $13.2 million in Q3 2025 and bottomed at $449000.0 in Q2 2024.
  • Average Interest Expenses over 5 years is $5.7 million, with a median of $6.2 million recorded in 2021.
  • Peak YoY movement for Interest Expenses: plummeted 83.67% in 2023, then soared 2348.33% in 2025.
  • A 5-year view of Interest Expenses shows it stood at $6.5 million in 2021, then tumbled by 33.69% to $4.3 million in 2022, then tumbled by 68.38% to $1.4 million in 2023, then skyrocketed by 590.9% to $9.4 million in 2024, then skyrocketed by 30.36% to $12.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Interest Expenses were $12.3 million in Q4 2025, $13.2 million in Q3 2025, and $11.0 million in Q2 2025.